Hairui Li

Title: The Innovations of Hairui Li

Introduction

Hairui Li is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of modified recombinant human endostatin. His work focuses on enhancing the efficacy and stability of therapeutic agents used in cancer treatment.

Latest Patents

Hairui Li holds a patent for a modified recombinant human endostatin, which is characterized by the structure CHO—(CHCHO)—CHCHCH—NH-Endostar. The average molecular weight of this compound ranges from 20-40 kD. This innovative formulation enhances stability in vivo, improves blood drug concentration, and prolongs the half-life of the drug. Additionally, it markedly increases the activity of inhibiting endothelial cell proliferation, thereby reducing the required drug dosage and administration frequency. The patent also outlines its application in preparing anti-tumor pharmaceutical compositions.

Career Highlights

Throughout his career, Hairui Li has worked with prominent companies in the pharmaceutical industry. He has been associated with Jiangsu Simcere Pharmaceutical R&D Co., Ltd and Shandong Xiansheng Maidejin Biological Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Hairui Li has collaborated with notable professionals in his field, including Xiangdong Gao and Wenbing Yao. These collaborations have further enriched his research and development efforts.

Conclusion

Hairui Li's contributions to the field of pharmaceuticals, particularly through his patent on modified recombinant human endostatin, demonstrate his commitment to advancing cancer treatment. His work not only enhances drug efficacy but also paves the way for more effective therapeutic strategies.